RADIATION THERAPY ONCOLOGY GROUP RTOG 0246 A PHASE II STUDY OF A PACLITAXEL-BASED CHEMORADIOTHERAPY REGIMEN WITH SELECTIVE SURGICAL SALVAGE FOR RESECTABLE LOCOREGIONALLY ADVANCED CARCINOMA OF THE ESOPHAGUS